Comment

. 2015 Oct 27;132(17):e213-4.

doi: 10.1161/CIRCULATIONAHA.115.017260.

Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"

Affiliations

¹ Cardiothoracic Pharmacology, Vascular Biology, National Heart and Lung Institute, Imperial College, London, UK.
² The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, London, UK.
³ Cardiothoracic Pharmacology, Vascular Biology, National Heart and Lung Institute, Imperial College, London, UK, King Fahad Cardiac Center, King Saud University, Riyadh, Saudi Arabia.
⁴ MRC Clinical Sciences, Imperial College London, Nitric Oxide Signalling Group, Hammersmith Hospital, London, UK.
⁵ School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK.
⁶ Institute of Clinical Pharmacology, Johann Wolfgang Goethe-University, Frankfurt, Germany.

PMID: 26503755
DOI: 10.1161/CIRCULATIONAHA.115.017260

Free article

Comment

Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"

Blerina Ahmetaj-Shala et al. Circulation. 2015.

Free article

. 2015 Oct 27;132(17):e213-4.

doi: 10.1161/CIRCULATIONAHA.115.017260.

Affiliations

¹ Cardiothoracic Pharmacology, Vascular Biology, National Heart and Lung Institute, Imperial College, London, UK.
² The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, London, UK.
³ Cardiothoracic Pharmacology, Vascular Biology, National Heart and Lung Institute, Imperial College, London, UK, King Fahad Cardiac Center, King Saud University, Riyadh, Saudi Arabia.
⁴ MRC Clinical Sciences, Imperial College London, Nitric Oxide Signalling Group, Hammersmith Hospital, London, UK.
⁵ School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK.
⁶ Institute of Clinical Pharmacology, Johann Wolfgang Goethe-University, Frankfurt, Germany.

PMID: 26503755
DOI: 10.1161/CIRCULATIONAHA.115.017260

No abstract available

PubMed Disclaimer

Comment on

Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs.
Ahmetaj-Shala B, Kirkby NS, Knowles R, Al'Yamani M, Mazi S, Wang Z, Tucker AT, Mackenzie L, Armstrong PC, Nüsing RM, Tomlinson JA, Warner TD, Leiper J, Mitchell JA. Ahmetaj-Shala B, et al. Circulation. 2015 Feb 17;131(7):633-42. doi: 10.1161/CIRCULATIONAHA.114.011591. Epub 2014 Dec 9. Circulation. 2015. PMID: 25492024 Free PMC article.
Letter by Kruszelnicka et al regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs".
Kruszelnicka O, Wieczorek-Surdacka E, Surdacki A. Kruszelnicka O, et al. Circulation. 2015 Oct 27;132(17):e212. doi: 10.1161/CIRCULATIONAHA.115.015383. Circulation. 2015. PMID: 26503754 No abstract available.

Cited by

Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective.
Bindu S, Mazumder S, Bandyopadhyay U. Bindu S, et al. Biochem Pharmacol. 2020 Oct;180:114147. doi: 10.1016/j.bcp.2020.114147. Epub 2020 Jul 10. Biochem Pharmacol. 2020. PMID: 32653589 Free PMC article. Review.
Ibuprofen arginate retains eNOS substrate activity and reverses endothelial dysfunction: implications for the COX-2/ADMA axis.
Kirkby NS, Tesfai A, Ahmetaj-Shala B, Gashaw HH, Sampaio W, Etelvino G, Leão NM, Santos RA, Mitchell JA. Kirkby NS, et al. FASEB J. 2016 Dec;30(12):4172-4179. doi: 10.1096/fj.201600647R. Epub 2016 Sep 6. FASEB J. 2016. PMID: 27601438 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

MC_U120097118/MRC_/Medical Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"

Affiliations

Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Research Materials

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Research Materials